Next Article in Journal
Relationship between Cholesterol-Related Lipids and Severe Acute Pancreatitis: From Bench to Bedside
Previous Article in Journal
Comparison of the Effectiveness of Liposuction for Lower Limb versus Upper Limb Lymphedema
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Rhegmatogenous Retinal Detachment in Musculocontractural Ehlers–Danlos Syndrome Caused by Biallelic Loss-of-Function Variants of Gene for Dermatan Sulfate Epimerase

1
Kyorin Eye Center, School of Medicine, Kyorin University, 6-20-2 Shinkawa, Mitaka 181-8611, Tokyo, Japan
2
Department of Ophthalmology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma 350-0495, Saitama, Japan
3
Center for Medical Genetics, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku, Tokyo 160-8582, Tokyo, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(5), 1728; https://doi.org/10.3390/jcm12051728
Submission received: 28 November 2022 / Revised: 12 February 2023 / Accepted: 19 February 2023 / Published: 21 February 2023
(This article belongs to the Section Ophthalmology)

Abstract

:
Musculocontractural Ehlers–Danlos syndrome, caused by biallelic loss-of-function variants for dermatan sulfate epimerase (mcEDS-DSE), is a rare connective tissue disorder. Eight patients with mcEDS-DSE have been described with ocular complications, including blue sclera, strabismus, high refractive errors, and elevated intraocular pressure. However, a case with rhegmatogenous retinal detachment (RRD) has not been reported. We report our findings in a 24-year-old woman who was diagnosed with mcEDS-DSE in childhood and presented to our clinic with an RRD in the left eye. The RRD extended to the macula and was associated with an atrophic hole. The patient underwent scleral buckling surgery and cryopexy with drainage of subretinal fluid through a sclerotomy under local anesthesia. The sclera did not appear blue but was very thin at the sclerotomy site. The patient developed frequent bradycardia during the surgery. Subretinal or choroidal hemorrhages were not observed intraoperatively; however, a peripapillary hemorrhage was observed one day after operation. The retina was reattached postoperatively, and the peripapillary hemorrhage was absorbed after one month. The peripapillary retinal hemorrhages, thin sclera, and bradycardia were most likely due to the fragility of the eye. The genetic diagnosis of mcEDS-DSE played an important role before and during the surgery by alerting the surgeons to possible surgical complications due to the thin sclera.

1. Introduction

Recent advances in genetic diagnosis have increased the number of cases in which a genetic diagnosis is possible, even for rare diseases. It is expected that the ability to predict the phenotype will identify possible complications that might arise during surgery.
Ehlers–Danlos syndrome (EDS) is an inherited connective tissue disorder characterized by hyperextensibility of the skin, hypermobility, and tissue fragility [1]. Musculocontractural Ehlers–Danlos syndrome (mcEDS) is a subtype of EDS that is due to a deficiency in systemic dermatan sulfate [1]. This deficiency results from defective biosynthesis of dermatan sulfate caused by a biallelic loss-of-function variant of carbohydrate sulfotransferase 14 (CHST14, mcEDS-CHST14) or dermatan sulfate epimerase (DSE, mcEDS-DSE) [2,3].
Patients with mcEDS are characterized by developmental abnormalities, e.g., congenital contractures of multiple joints, and abnormalities of the cardiovascular system, respiratory system, urinary system, central nervous system, and ocular systems. There is a progressive increase in the fragility of the connective tissue, resulting in hyperextension and skin fragility, generalized joint laxity, recurrent joint dislocation, skeletal deformities, and giant subcutaneous hematomas [2,3]. mcEDS-DSE is a congenital multisystem disorder with symptoms similar to mcEDS-CHST14; however, the severity of the symptoms is lower in mcEDS-DSE [3]. Eight mcEDS-DSE patients, including three men and five women (two Indian, two Spanish, one Portuguese, one Pakistani, one Turkish, and one unknown) have been described in the literature with ocular complications, including blue sclera, strabismus, high refractive error, and elevated intraocular pressure [3,4,5]. These eight patients with mcEDS-DSE were reported to have craniofacial hypertelorism in six of six cases (100%), down-slanting palpebral fissures in seven of eight (88%), ear deformity in seven of eight (88%), congenital multiple contractures in seven of eight (88%), talipes equinovarus in six of eight (75%), long or slender finger shape characteristics in eight of eight (100%), progressive foot deformities in six of six (100%), skin hyperextensibility in three of seven (43%), fine or acrogeria-like palmar creases in seven of eight (88%), and large subcutaneous hematoma in four of five (80%) [5]. However, no complications of retinal detachment (RD) have been reported. By contrast, 6 of the 41 patients with mcEDS-CHST14 were reported to have RD [3].
We report our findings in a young woman with genetically diagnosed mcEDS-DSE who developed a unilateral RRD that was treated successfully with scleral buckling surgery. The surgery was performed with prior knowledge of the possible complications associated with the tissue abnormalities in the eyes in mcEDS-DSE.

2. Case Report

A 24-year-old young woman noticed a visual field defect in her left eye. She had been diagnosed with mcEDS in her childhood at Keio University Hospital. Genetic analysis found that mcEDS was caused by a biallelic loss-of-function variant of DSE. An exome analysis revealed that she had a compound heterozygous missense and frameshift mutations in exon 6 of the DSE gene: c. 1633T>G, p. Tyr545Asp, and c.1160delG, p.Gly387Alafs*14. She was diagnosed with unilateral RRD without macular involvement at a local hospital but declined surgery because of the many known complications associated with mcEDS.
Then, she visited the Kyorin Eye Center, and our examination showed that her best corrected visual acuity (BCVA) in the left eye was 20/33, the refractive error (spherical equivalent) was −9.0 diopters (D), and the axial length was 27.7 mm. Slit lamp examinations did not show a blue sclera (Figure 1), and the cornea, anterior chamber, lens, and vitreous body were clear.
Fundus examinations detected an RRD in the nasal and inferior quadrants that was located near the macula and was associated with an atrophic hole in the inferonasal quadrants and lattice degeneration in the temporal quadrants. The posterior vitreous was not detached. Fundus autofluorescence (FAF) examinations showed a hypo-FAF area corresponding to the RRD and hyper-FAF lesions corresponding to the subretinal fibrosis. However, we did not observe peripapillary starfish hypo-FAF caused by a fissure in Bruch’s membrane, which is observed in eyes with retinal angioid streaks and which is one of the subtypes of EDS (Figure 2). The right eye appeared to be normal except for a myopic change in the fundus.
Because of the fragility of the eye due to mcEDS, minimal surgery was planned with minimal deformation of the eyeball. Before the scleral buckling surgery, retinal photocoagulation was performed for the lattice degeneration at the temporal quadrant without an RRD to reduce the area needing the scleral buckle. Then, the scleral buckling surgery was performed for the RRD under local anesthesia. The surgery was begun by placing 3.0 tractional silk sutures on the inferior and internal rectus muscles to manage the position of the eyeball. During the placement of the tractional sutures, prominent bradycardia was observed, so it was necessary to proceed with the surgery while reducing the traction on the eyeball. Retinal cryopexy was performed around the atrophic holes, and a #506 silicone sponge buckle was sutured between 6 and 11 o’clock. A scleral incision was made at 8 o’clock to drain the subretinal fluid, and a very thin sclera was found at the sclerotomy site (Figure 3).
The site of the sclerotomy was sufficiently coagulated, and then the uvea was perforated with a fine needle. The thick subretinal fluid was drained without depressing the sclera to avoid deformation of the eyeball and causing subretinal hemorrhage due to the fragility of the sclera and Bruch’s membrane. We did not find any subretinal or choroidal hemorrhages, including at the sclerotomy site during the operation, and the surgery was completed after confirming that the subretinal fluid was reduced and the atrophic hole was positioned beneath the scleral buckle.
On the day after the surgery, the atrophic hole was found to be beneath the buckle in a proper position, and the subretinal fluid was reduced, but a peripapillary subretinal hemorrhage that extended to the upper and lower arcade vessels was observed (Figure 4). The postoperative FAF image showed a hypo-FAF area corresponding to the peripapillary hemorrhage. The peripapillary hemorrhage disappeared one month after the surgery and the FAF image showed no peripapillary starfish hypo-FAF lesion suggestive of Bruch’s membrane or RPE cracks, as was observed preoperatively.

3. Discussion

EDS is a systemic disorder that causes degeneration of the ocular connective tissue and a thinning of the retina due to scleral extensions and vitreous degeneration [6]. These abnormalities are risk factors for retinal detachments [7]. Previous studies have reported cases of EDS with RD (Table 1) [8,9,10,11,12,13,14].
Minatogawa and associates [15] reviewed 66 patients with mcEDS-CHST14, including 48 patients who had been reported earlier. The ophthalmologic complications were refractive errors including myopia, astigmatism, hyperopia, and amblyopia. As opposed to eyes with mcEDS-DSE, RD was present in six patients whose median age was 15.5 years with a range of 9 to 20 years [10,11,12,15] (Table 1). Retinal angioid streaks were present in two patients [15]. Blindness was present in six patients, and it was associated with glaucoma, macular bleeding, lacquer crack in Bruch’s membrane, and RRD [15].
The CHST14 gene encodes N-acetylgalactosamine 4-O-sulfotransferase 1 (D4ST1), which catalyzes the 4-O sulfation of N-acetylgalactosamine and is involved in the biosynthesis of dermatan sulfate. Dermatan sulfate plays an important role in human development and extracellular-matrix maintenance [16]. Abnormalities in dermatan acid result in severe systemic complications, but mutations in DSE encoding dermatan sulfate epimerase-1 (DS-epi1) partially maintain the dermatan sulfate activity [17]. Thus, no severe systemic complications have been reported compared with the CHST14 mutations [3].
Our case of mcEDS-DSE had RRD that was successfully reattached with scleral buckling surgery with precautions taken because of the fragility of the eye. The patient did not have vitreous degeneration and blue sclera, but the RRD in the left eye was most likely due to high myopia, which is a risk factor for RRD.
The intraoperative observations showed that the sclera was very thin and required careful manipulations, and the heart monitor needed to be continuously watched because the manipulation of the ocular tissue was associated with bradycardia. Creating the scleral incision for subretinal fluid drainage and placing sutures for the scleral buckling also required careful manipulations. Intraoperatively, no subretinal and choroidal hemorrhages were detected, but intraretinal and subretinal hemorrhages around the optic disc extending to the upper and lower arcade vessels were detected postoperatively. FAF examinations showed no peripapillary starfish hypo-FAF lesions pre- and postoperatively which would have indicated the presence of cracks in Bruch’s membrane or RPE layers as with retinal angioid streaks. These findings suggest that the subretinal hemorrhage may have been from peripapillary vessels due to the scleral fragility and vascular fragility [18,19]. The placement of the scleral buckle may have stressed the area around the optic nerve where the shape of the eye changes the most, causing the breakage of peripapillary vessels and leading to hemorrhage. The intraoperative surgical procedures or a rupture of the Bruch’s membrane, as is seen in simple hemorrhages in eyes with high myopia [20], did not appear to be the cause of the peripapillary subretinal hemorrhage according to the intraoperative and postoperative findings.
A previous report of vitrectomy for RRD in type VI EDS reported significant intraoperative hemorrhages and difficulty in closing the scleral wound due to a thinning of the sclera (Table 1) [9]. The vascular fragility in EDS is due to the fragility of the perivascular connective tissue, and it is especially prominent in type IV (vascular) EDS, which is caused by a molecular defect in type Ⅲ collagen. However, the other subtypes are also known to have varying degrees of vascular fragility [18,19]. Although the triggers for the hemorrhages are not clear, it is possible that acute changes in the intraocular pressure due to drainage or ocular deformations with traction on the eye during the surgical manipulation may have contributed to the bleeding. Severe intraoperative bradycardia due to the oculocardiac reflex in response to traction of the extraocular muscles was also prominently observed in our patient. Previous studies have reported autonomic failure due to the presence of cardiovascular dysfunction in EDS, and intraoperative systemic management should be carefully monitored [21].
In earlier studies of RDs in EDS patients, vitrectomy was used to treat RD because of the presence of scleral atrophy and thinning [9,14]. In another case, vitrectomy with a 360-degree scleral graft was used because of the extensive scleral ectasia and sclera ruptures during the reattachment of the RD in EDS patients [13]. In these cases, the subtype of EDS was not reported. However, in our case, although intraoperative scleral thinning and postoperative retinal hemorrhage were observed, scleral sutures of silicone sponge and scleral incision could be performed as usual while expecting possible complications from the fragility of the eyeball. Our case had mcEDS-DSE with an EDS mutation, and the maintenance of the partial activity of dermatan sulfate preserved the architecture of the ocular tissues. This allowed the scleral buckling surgery to be performed, unlike in eyes with conventional EDS. Thus, identifying the causative gene and phenotypes will provide important information for surgical strategies.
Our study has several limitations. First, this was a single case study, and statistical analysis could not be performed. Nevertheless, scleral buckling surgery was performed successfully. Second, the eye was highly myopic, which is a risk factor for developing RRD and one of the eye complications in mcEDS. Thus, further studies on a larger number of mcEDS-DSE patients are needed.

4. Conclusions

We conclude that cases of mcEDS-DSE with RRD can be successfully treated by scleral buckling surgery. We also conclude that knowing the genetic diagnosis will provide helpful information on possible complications during the intra- and postoperative periods. We recommend that a preoperative genetic diagnosis be made in all cases of inherited connective tissue disorders and that the surgical procedures be designed appropriately.

Author Contributions

K.K. and M.I. cared for the patient. Y.Y. and M.I. prepared the figures, collected data, and analyzed the ophthalmological findings. K.K., T.U. and M.Y. analyzed genetic findings. T.K. and T.I. gave critical suggestions. Y.Y. and M.I. prepared the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Initiative on Rare and Undiagnosed Diseases (grant number JP22ek0109549) from the Japan Agency for Medical Research and Development.

Institutional Review Board Statement

This study was approved by the Institutional Review Committee of Kyorin University School of Medicine. Approval Code: 863-02; Approval Date: 9 March 2022.

Informed Consent Statement

The patients received a detailed explanation of the surgical and ophthalmic procedures, and all signed an informed consent form. The patients consented to our review of their medical records and their anonymized use in medical publications. The patient consent for this study was obtained in an opt-out format.

Data Availability Statement

The data presented in this study are available upon request from the first author (Y.Y.).

Acknowledgments

The authors thank Duco Hamasaki, Emeritus of the Bascom Palmer Eye Institute, University of Miami, Miami, Florida, for discussions and thorough editing of the manuscript.

Conflicts of Interest

Y.Y.: personal fees (lecture fees) from Novartis Pharma K.K., Bayer AG, Carl Zeiss Meditec AG, Novartis Pharma K.K., KOWA, AMO., and CHUGAI PHARMACEUTICAL CO., LTD outside the submitted work. T.K.: research grants from Ellex and personal fees (lecture fees) from Alcon Laboratories, Inc., Novartis Pharma K.K., Bayer AG, Carl Zeiss Meditec AG, Novartis Pharma K.K., Santen Pharmaceutical Co., Ltd., and Senju Pharmaceutical Co., Ltd. AMO. outside the submitted work. T.I.: nothing to declare. T.M.: nothing to declare. M.Y.: nothing to declare. M.I.: research grants from Alcon Laboratories, Inc. and personal fees (lecture fees) from Alcon Laboratories, Inc., Novartis Pharma K.K., Bayer AG, Carl Zeiss Meditec AG, and Novartis Pharma K.K.: Santen Pharmaceutical Co., Ltd. and Senju Pharmaceutical Co., Ltd. AMO, Logitec and Design outside the submitted work.

References

  1. Malfait, F.; Francomano, C.; Byers, P.; Belmont, J.; Berglund, B.; Black, J.; Bloom, L.; Bowen, J.M.; Brady, A.F.; Burrows, N.P.; et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am. J. Med. Genet. C Semin. Med. Genet. 2017, 175, 8–26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kosho, T.; Mizumoto, S.; Watanabe, T.; Yoshizawa, T.; Miyake, N.; Yamada, S. Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome. Genes 2019, 11, 43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Lautrup, C.K.; Teik, K.W.; Unzaki, A.; Mizumoto, S.; Syx, D.; Sin, H.H.; Nielsen, I.K.; Markholt, S.; Yamada, S.; Malfait, F.; et al. Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency. Mol. Genet. Genomic. Med. 2020, 8, e1197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Muller, T.; Mizumoto, S.; Suresh, I.; Komatsu, Y.; Vodopiutz, J.; Dundar, M.; Straub, V.; Lingenhel, A.; Melmer, A.; Lechner, S.; et al. Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome. Hum. Mol. Genet. 2013, 22, 3761–3772. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Schirwani, S.; Metcalfe, K.; Wagner, B.; Berry, I.; Sobey, G.; Jewell, R. DSE associated musculocontractural EDS, a milder phenotype or phenotypic variability. Eur. J. Med. Genet. 2020, 63, 103798. [Google Scholar] [CrossRef]
  6. Sebag, J. Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefes Arch Clin. Exp. Ophthalmol. 2004, 242, 690–698. [Google Scholar] [CrossRef]
  7. Bechrakis, N.E.; Dimmer, A. [Rhegmatogenous retinal detachment: Epidemiology and risk factors]. Ophthalmologe 2018, 115, 163–178. [Google Scholar] [CrossRef] [Green Version]
  8. Beighton, P. Serious ophthalmological complications in the Ehlers-Danlos syndrome. Br. J. Ophthalmol. 1970, 54, 263–268. [Google Scholar] [CrossRef] [Green Version]
  9. Bodanowitz, S.; Hesse, L.; Pöstgens, H.; Kroll, P. [Retinal detachment in Ehlers-Danlos syndrome Treatment by pars plana vitrectomy]. Ophthalmologe 1997, 94, 634–637. [Google Scholar] [CrossRef]
  10. Yasui, H.; Adachi, Y.; Minami, T.; Ishida, T.; Kato, Y.; Imai, K. Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndrome. Am. J. Hematol. 2003, 72, 71–72. [Google Scholar] [CrossRef] [Green Version]
  11. Malfait, F.; Syx, D.; Vlummens, P.; Symoens, S.; Nampoothiri, S.; Hermanns-Le, T.; Van Laer, L.; De Paepe, A. Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene. Hum. Mutat. 2010, 31, 1233–1239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Janecke, A.R.; Li, B.; Boehm, M.; Krabichler, B.; Rohrbach, M.; Muller, T.; Fuchs, I.; Golas, G.; Katagiri, Y.; Ziegler, S.G.; et al. The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. Am. J. Med. Genet. A 2016, 170A, 103–115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Whitlow, S.; Idrees, Z. RD repair using 360-degree scleral graft for extensive scleral ectasia in a patient with Ehlers Danlos syndrome. Am. J. Ophthalmol. Case Rep. 2020, 17, 100554. [Google Scholar] [CrossRef] [PubMed]
  14. Lumi, X.; Bergant, G.; Lumi, A.; Mahnic, M. Outcomes of vitrectomy for retinal detachment in a patient with Ehlers-Danlos syndrome type IV: A case report. J. Med. Case Rep. 2021, 15, 249. [Google Scholar] [CrossRef]
  15. Minatogawa, M.; Unzaki, A.; Morisaki, H.; Syx, D.; Sonoda, T.; Janecke, A.R.; Slavotinek, A.; Voermans, N.C.; Lacassie, Y.; Mendoza-Londono, R.; et al. Clinical and molecular features of 66 patients with musculocontractural Ehlers-Danlos syndrome caused by pathogenic variants in. J. Med. Genet. 2022, 59, 865–877. [Google Scholar] [CrossRef]
  16. Dündar, M.; Müller, T.; Zhang, Q.; Pan, J.; Steinmann, B.; Vodopiutz, J.; Gruber, R.; Sonoda, T.; Krabichler, B.; Utermann, G.; et al. Loss of dermatan-4-sulfotransferase 1 function results in adducted thumb-clubfoot syndrome. Am. J. Hum. Genet. 2009, 85, 873–882. [Google Scholar] [CrossRef] [Green Version]
  17. Syx, D.; Van Damme, T.; Symoens, S.; Maiburg, M.C.; van de Laar, I.; Morton, J.; Suri, M.; Del Campo, M.; Hausser, I.; Hermanns-Lê, T.; et al. Genetic heterogeneity and clinical variability in musculocontractural Ehlers-Danlos syndrome caused by impaired dermatan sulfate biosynthesis. Hum. Mutat. 2015, 36, 535–547. [Google Scholar] [CrossRef]
  18. Malfait, F.; De Paepe, A. Bleeding in the heritable connective tissue disorders: Mechanisms, diagnosis and treatment. Blood. Rev. 2009, 23, 191–197. [Google Scholar] [CrossRef]
  19. De Paepe, A.; Malfait, F. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders. Br. J. Haematol. 2004, 127, 491–500. [Google Scholar] [CrossRef]
  20. Li, H.; Wen, F.; Wu, D.Z.; Luo, G.; Huang, S.; Guan, T.; Liu, C. Fundus analysis and visual prognosis of macular hemorrhage in pathological myopia without choroidal neovasculopathy. Yan Ke Xue Bao 2004, 20, 57–62. [Google Scholar]
  21. De Wandele, I.; Rombaut, L.; Leybaert, L.; Van de Borne, P.; De Backer, T.; Malfait, F.; De Paepe, A.; Calders, P. Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome. Semin. Arthritis Rheum. 2014, 44, 93–100. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Photograph of the anterior segment of the right and left eyes. There is no evidence of a blue sclera, corneal opacities, or cataracts in either eye ((A): right eye, (B): left eye).
Figure 1. Photograph of the anterior segment of the right and left eyes. There is no evidence of a blue sclera, corneal opacities, or cataracts in either eye ((A): right eye, (B): left eye).
Jcm 12 01728 g001
Figure 2. Preoperative widefield fundus photograph and fundus autofluorescence (FAF) image of the left eye. (A): The widefield fundus photograph shows the retinal detachment in the nasal and inferior quadrants adjacent to the macula. It is associated with an atrophic hole in the inferonasal quadrants and lattice degeneration in the temporal quadrants. (B): FAF image shows a hypo-FAF area corresponding to retinal detachment and hyper-FAF lesions corresponding to the subretinal fibrosis, but no peripapillary starfish hypo-FAF was observed in the eye with retinal angioid streaks.
Figure 2. Preoperative widefield fundus photograph and fundus autofluorescence (FAF) image of the left eye. (A): The widefield fundus photograph shows the retinal detachment in the nasal and inferior quadrants adjacent to the macula. It is associated with an atrophic hole in the inferonasal quadrants and lattice degeneration in the temporal quadrants. (B): FAF image shows a hypo-FAF area corresponding to retinal detachment and hyper-FAF lesions corresponding to the subretinal fibrosis, but no peripapillary starfish hypo-FAF was observed in the eye with retinal angioid streaks.
Jcm 12 01728 g002
Figure 3. Intraoperative photograph of the inferonasal sclera during sclerotomy. (A): Scleral incision was made inferior to the internal rectus muscle to drain the subretinal fluid. Blue sclera was not observed. (B): Magnified image shows that the sclera at the site of sclerotomy (yellow arrow) was very thin. No choroidal hemorrhage could be seen at the sclerotomy site during the drainage.
Figure 3. Intraoperative photograph of the inferonasal sclera during sclerotomy. (A): Scleral incision was made inferior to the internal rectus muscle to drain the subretinal fluid. Blue sclera was not observed. (B): Magnified image shows that the sclera at the site of sclerotomy (yellow arrow) was very thin. No choroidal hemorrhage could be seen at the sclerotomy site during the drainage.
Jcm 12 01728 g003
Figure 4. Postoperative widefield fundus photograph and FAF image. (A): The postoperative widefield fundus photograph shows that the atrophic retinal hole was located in the area indented by the buckle and the subretinal fluid was reduced. However, a subretinal hemorrhage was observed around the optic disc and the upper and lower arcade vessels. (B): Postoperative FAF image shows a hypo-FAF area (yellow arrows) corresponding to the subretinal hemorrhage, but no peripapillary starfish hypo-FAF was observed. (C): Postoperative optical coherence tomographic image showing hyperreflective subretinal hemorrhage (yellow arrows) near the optic disc.
Figure 4. Postoperative widefield fundus photograph and FAF image. (A): The postoperative widefield fundus photograph shows that the atrophic retinal hole was located in the area indented by the buckle and the subretinal fluid was reduced. However, a subretinal hemorrhage was observed around the optic disc and the upper and lower arcade vessels. (B): Postoperative FAF image shows a hypo-FAF area (yellow arrows) corresponding to the subretinal hemorrhage, but no peripapillary starfish hypo-FAF was observed. (C): Postoperative optical coherence tomographic image showing hyperreflective subretinal hemorrhage (yellow arrows) near the optic disc.
Jcm 12 01728 g004
Table 1. Ocular and systemic complications in Ehlers–Danlos syndrome with retinal detachment.
Table 1. Ocular and systemic complications in Ehlers–Danlos syndrome with retinal detachment.
Authors, YearAgeSexSubtypeGene MutationSurgeryOcular ComplicationsSystemic Complications
Beighton P 1970 [8]36womanunknownunknownunknownhigh myopia, strabismus, congenital glaucoma, microcornea, blue sclerabilateral talipes equinovarus deformities of the feet, thoracolumbar kyphoscoliosis, frequent dislocations of both shoulders and subluxations, hiatus hernia, breast cystic masses
Bodanowitz S 1997 [9]47mantype VIunknownvitrectomyblue sclera, keratoconushyperpigmentation and scarring of the skin, hyperextensibility of the thumb end links
Yasui H et al., 2003 [10]23manmusculocontractural typeCHST14unknownnonehyperextensible skin and hypermobile joint, anemia, hematoma
Malfait F et al., 2010 [11]14 *womanmusculocontractural typeCHST14unknownhigh myopia, glaucomalarge fontanel, flexion–adduction contractures of the thumb, kyphoscoliosis, skin fragility, hiatal hernia, craniofacial abnormalities
Malfait F et al., 2010 [11]14 *womanmusculocontractural typeCHST14unknownhigh myopia, glaucomamuscular hypotonia, dislocations of the patellae, lumbar scoliosis, skin fragility
Janecke A et al., 2016 [12]45womanmusculocontractural typeCHST14unknowndown slanting palpebral fissures, blue sclerae, microcornea, myopia, circumscribed retinal degenerations at the peripherylaxity of joints, frequent bruising, delayed wound healing, skin fragility with prolonged bleeding, dermal hyperelasticity
Whitlow S et al. 2020 [13]33womantype VIunknownpneumatic retinopexy → vitrectomy and 360-degree scleral grafthigh myopiaunknown
Lumi X et al., 2021 [14]40mantype IVCOL3A1vitrectomyhigh myopiacolon perforation, muscle and arterial rupture in both lower limbs, recurrent shoulder joint luxation
Current case21womanmusculocontractural typedermatan sulfate epimerasescleral bucklinghigh myopia, thin sclerahyperextensible skin and hypermobile joint, prolonged bleeding, bradycardia
* = sisters.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yoshikawa, Y.; Koto, T.; Ishida, T.; Uehara, T.; Yamada, M.; Kosaki, K.; Inoue, M. Rhegmatogenous Retinal Detachment in Musculocontractural Ehlers–Danlos Syndrome Caused by Biallelic Loss-of-Function Variants of Gene for Dermatan Sulfate Epimerase. J. Clin. Med. 2023, 12, 1728. https://doi.org/10.3390/jcm12051728

AMA Style

Yoshikawa Y, Koto T, Ishida T, Uehara T, Yamada M, Kosaki K, Inoue M. Rhegmatogenous Retinal Detachment in Musculocontractural Ehlers–Danlos Syndrome Caused by Biallelic Loss-of-Function Variants of Gene for Dermatan Sulfate Epimerase. Journal of Clinical Medicine. 2023; 12(5):1728. https://doi.org/10.3390/jcm12051728

Chicago/Turabian Style

Yoshikawa, Yuji, Takashi Koto, Tomoka Ishida, Tomoko Uehara, Mamiko Yamada, Kenjiro Kosaki, and Makoto Inoue. 2023. "Rhegmatogenous Retinal Detachment in Musculocontractural Ehlers–Danlos Syndrome Caused by Biallelic Loss-of-Function Variants of Gene for Dermatan Sulfate Epimerase" Journal of Clinical Medicine 12, no. 5: 1728. https://doi.org/10.3390/jcm12051728

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop